Day: November 15, 2021

Quotient Limited Provides Second Quarter Fiscal 2022 Results

Quotient Limited Provides Second Quarter Fiscal 2022 Results

Alba by Quotient: Revenues exceeded guidance; Achieved year-over year growth in Q2 FY 2022 of 15.9% Financial Position: Available cash & short-term investments of $141.8 million Business Update: Communication issued on November 9, 2021; providing a progress update on development and upcoming commercialization JERSEY, Channel Islands, Nov. 15, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its financial results for the second quarter of fiscal year 2022 and filed the quarterly report on Form 10-Q. Alba by Quotient – Revenues exceeded guidance and continued to drive double digit growth. Generated $9.2 million product sales in the second quarter, growing 15.9% over Q2 of FY 2021. Alba’s sales to OEM...

Continue reading

Marathon Digital Holdings, Inc. Prices Upsized $650.0 Million Convertible Senior Notes Offering

Marathon Digital Holdings, Inc. Prices Upsized $650.0 Million Convertible Senior Notes Offering

LAS VEGAS, Nov. 15, 2021 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (Nasdaq: MARA), one of the largest enterprise Bitcoin self-mining companies in North America, today announced the pricing of its offering of $650,000,000 aggregate principal amount of 1.00% convertible senior notes due 2026 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $500,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on or about November 18, 2021, subject to the satisfaction of customary closing conditions. Marathon also granted the initial purchasers of the notes an option, for settlement within a period...

Continue reading

EverCommerce Announces Launch of Follow-On Offering

EverCommerce Announces Launch of Follow-On Offering

DENVER, Nov. 15, 2021 (GLOBE NEWSWIRE) — EverCommerce Inc. (Nasdaq: EVCM) (“EverCommerce”), a leading service commerce platform, announced today that it has commenced an underwritten public offering of its common stock. EverCommerce is offering 11,000,000 shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”). EverCommerce expects to grant the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, RBC Capital Markets, LLC and KKR Capital Markets LLC will act as lead book-running managers for the proposed offering. Barclays Capital Inc., Deutsche Bank Securities Inc., Jefferies...

Continue reading

Remitly to Present at Citi’s 2021 FinTech Conference

Remitly to Present at Citi’s 2021 FinTech Conference

SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a leading digital financial services provider for immigrants and their families, today announced that its management team will present at Citi’s 2021 FinTech Conference. Date: Wednesday, November 17, 2021 Time: 7:30am Pacific Time / 10:30am Eastern Time The presentation will be webcast live from Remitly’s investor relations website at https://ir.remitly.com/. A replay of the event will be available on the investor relations website following the presentation. About Remitly Remitly is a leading digital financial services provider for immigrants and their families in over 135 countries around the world. Its vision is to transform the lives of immigrants and their families by providing the most trusted financial services on the planet....

Continue reading

Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

Announced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead indications. Initiated a new pipeline research program focused on discovering novel psychedelics with a reduced cardiovascular risk profile compared to classic psychedelics (the “FT-200 Group”) and filed a provisional patent in connection to the composition of matter for the first molecule identified in the FT-200 Group. Continued to invest in best-in-class clinical infrastructure, with nine clinics currently in operation and nine locations under construction or about to commence construction. Commenced trading on the NASDAQ Global Select Market (“NASDAQ”) under the ticker symbol “FTRP”. As at September 30, 2021, Field Trip had approximately $88 million in unrestricted cash and cash equivalents...

Continue reading

Bitfarms Reports Record Q3 2021 Revenues, Up 22% from Q2 2021 and 559% from Q3 2020

Bitfarms Reports Record Q3 2021 Revenues, Up 22% from Q2 2021 and 559% from Q3 2020

– Grew Revenues to $44.8 Million, Up from $6.8 Million in Q3 2020 –– Achieved Record Profitability with Net Income of $23.7 Million, Up from a Net Loss of $4.8 Million in Q3 2020 – This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated August 16, 2021 to its short form base shelf prospectus dated August 12, 2021. TORONTO, Ontario and BROSSARD, Québec, Nov. 15, 2021 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF // TSXV: BITF), a global Bitcoin self-mining company, reported its financial results for the quarter ended September 30, 2021. All financial references are in US dollars. During Q3 2021, Bitfarms mined 1,051 Bitcoin (BTC), up 38% from 759 BTC in Q2 2021, and reduced the average cost of BTC production* to $6,900/BTC, down 23% from $9,000/BTC in Q2...

Continue reading

Ketamine One Provides Update on Management Cease Trade Order

Ketamine One Provides Update on Management Cease Trade Order

VANCOUVER, British Columbia, Nov. 15, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is providing this update on the status of a management cease trade order (the “MCTO“) granted on November 1, 2021 by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order (“NP 12-203“). On November 1, 2021, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements, annual information form and management’s discussion and analysis for the fiscal year ended July 31, 2021 (the “Annual Filings“) beyond...

Continue reading

VERB Publishes Management’s Prepared Remarks During Third Quarter 2021 Earnings Conference Call

VERB Publishes Management’s Prepared Remarks During Third Quarter 2021 Earnings Conference Call

New Client SaaS Contracts Executed in Q3 2021 Represent the Highest Base Contract Revenue Ever Produced in a Single Quarter in Company History Total Digital Revenue Recognized in Q3 Increased 30% over Prior Quarter, and Now Represents 81% of Total Revenue, Up from 64% Last Year SaaS Recurring Revenue Up 25% Year over Year and Up 15% over Q2 Non-SaaS Digital Revenue Increased 144% over Q2 and 42% Year over Year Combined Revenue Up More than 21% over Q2 Launched Professional Sports Vertical, Partnering with Pittsburgh Penguins for Verb Interactive Video Sales Enablement Platform to Drive Ticket Sales and Fan Engagement; Expects More Professional Sports Team Announcements to Follow NEWPORT BEACH, Calif. and SALT LAKE CITY, Nov. 15, 2021 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the...

Continue reading

Greenbacker Delivers Third Quarter Results

Greenbacker Delivers Third Quarter Results

Company shows significant quarter-over-quarter and year-over-year growth across revenue, production, and fleet size, as well as expanding land stewardship goals Wind tower components for Greenbacker’s RoxWind asset Greenbacker COO Matt Murphy (center) and team members welcomed the arrival of towers and turbines for RoxWind—GREC’s 15.3-MW wind project in Roxbury, ME. NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) — Greenbacker Renewable Energy Company LLC (“Greenbacker,” “GREC,” or the “Company”), a leading owner and operator of sustainable infrastructure and energy efficiency projects, recently announced financial results for the three-month period ended September 30, 2021.1 A number of positive trends were evident, both on a quarter-over-quarter basis (comparing the third quarter of 2021 with the second quarter...

Continue reading

Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates

Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates

SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today reported financial results for the third quarter of 2021 and recent corporate updates. “In the third quarter, we successfully completed our convertible note financing of $15 million that provided us with the necessary proceeds to continue our advancement of our lead clinical trial programs,” said Dr. Lynn Kirkpatrick, CEO of Ensysce. “As previously announced, we commenced our second study of our TAAP opioid, PF614, in early September, and through this study, we aim to demonstrate the correlation between PF614 to Oxycontin, and how Ensysce can begin...

Continue reading